1163 - Testing for gastric cancer for access to trastuzumab

Page last updated: 13 July 2016

Application Detail

Status

Closed

Description of Medical Service

In-situ hybridisation (ISH) for PBS listing of trastuzumab.

Description of Medical Condition

Previously untreated human epidermal growth factor receptor 2 (HER2) positive inoperable locally advanced or metastatic gastric or gastro-oesophageal cancer.

Reason for Application[</h3>]New MBS item

Medical Service Type

Investigative

Previous Application Number

Not Applicable

Associated Documentation

Application Form

-

PICO Confirmation

Date of released for comment 25 July 2011
Consultation Decision Analytic Protocol (DAP) (PDF 718 KB)
Consultation Decision Analytic Protocol (DAP) (Word 1283 KB)
Date of closed for comments 18 August 2011

14 - 15 September 2011
Final Decision Analytic Protocol (DAP) (PDF 542 KB)
Final Decision Analytic Protocol (DAP) (Word 1319 KB)

Assessment Report

-

Public Summary Document

Public Summary Document (PDF 697 KB)
Public Summary Document (Word 756 KB)

Meetings for this Application

PASC

7 July 2011

ESC

11 - 12 October 2012

MSAC

29 - 30 November 2012